Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
68.21
Dollar change
-1.29
Percentage change
-1.86
%
IndexRUT P/E- EPS (ttm)-3.71 Insider Own20.86% Shs Outstand12.82M Perf Week48.06%
Market Cap869.84M Forward P/E- EPS next Y-4.51 Insider Trans0.00% Shs Float10.28M Perf Month41.66%
Income-55.44M PEG- EPS next Q-1.22 Inst Own93.10% Short Float9.09% Perf Quarter96.63%
Sales0.93M P/S935.31 EPS this Y-250.46% Inst Trans22.91% Short Ratio7.15 Perf Half Y109.88%
Book/sh11.93 P/B5.72 EPS next Y-2.20% ROA-40.49% Short Interest0.93M Perf Year403.02%
Cash/sh12.07 P/C5.65 EPS next 5Y25.10% ROE-47.27% 52W Range12.49 - 73.59 Perf YTD251.96%
Dividend Est.- P/FCF- EPS past 5Y-16.09% ROI-33.40% 52W High-7.31% Beta1.48
Dividend TTM- Quick Ratio12.17 Sales past 5Y-20.00% Gross Margin-323.57% 52W Low446.12% ATR (14)5.31
Dividend Ex-Date- Current Ratio12.17 EPS Y/Y TTM-338.79% Oper. Margin-8756.32% RSI (14)73.14 Volatility15.65% 8.22%
Employees91 Debt/Eq0.09 Sales Y/Y TTM- Profit Margin-5993.62% Recom1.14 Target Price51.40
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q-2842.05% Payout- Rel Volume1.39 Prev Close69.50
Sales Surprise- EPS Surprise-3.85% Sales Q/Q- EarningsAug 09 BMO Avg Volume130.63K Price68.21
SMA2028.10% SMA5048.01% SMA20075.98% Trades Volume180,961 Change-1.86%
Date Action Analyst Rating Change Price Target Change
Jun-27-24Initiated BMO Capital Markets Outperform $65
Jun-11-24Initiated Robert W. Baird Outperform $54
Apr-29-24Initiated Leerink Partners Outperform $46
Mar-21-24Initiated William Blair Outperform $61
Jan-08-24Initiated H.C. Wainwright Buy $45
Jan-05-24Initiated Stifel Buy $31
Jan-04-24Initiated TD Cowen Outperform
Nov-05-24 07:54AM
Nov-04-24 07:30AM
Oct-21-24 07:30AM
Aug-09-24 02:52PM
07:30AM
07:30AM Loading…
Aug-07-24 07:30AM
Jul-02-24 07:30AM
Jul-01-24 07:30AM
Jun-19-24 09:23AM
Jun-18-24 09:26AM
Jun-05-24 07:30AM
Jun-03-24 07:30AM
May-10-24 01:54PM
07:30AM
May-07-24 06:19AM
04:36PM Loading…
Apr-22-24 04:36PM
Mar-20-24 05:31AM
Mar-18-24 04:14PM
Mar-04-24 07:30AM
Feb-29-24 07:30AM
Jan-16-24 07:00AM
Jan-05-24 07:00AM
Dec-19-23 07:00AM
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.